title: The Indiana Chronic Disease Management Program's impact on medicaid claims: a longitudinal, statewide evaluation.
abstract: BACKGROUND
  : Disease management programs have grown in popularity over the past decade as a strategy to curb escalating healthcare costs for persons with chronic diseases.
  
  
  OBJECTIVE
  : To evaluate the effect of the Indiana Chronic Disease Management Program (ICDMP) on the longitudinal changes in Medicaid claims statewide.
  
  
  METHODS
  : Phased implementation of a chronic disease management program in 3 regions of the state. Fourteen repeated cohorts of Medicaid members were drawn over a period of 3.5 years and the trends in claims were evaluated using a repeated measures model.
  
  
  METHODS
  : A total of 44,218 Medicaid members with diabetes and/or congestive heart failure in 3 geographic regions in Indiana.
  
  
  RESULTS
  : Across all 3 regions and both disease classes, we found a flattening of cost trends between the pre- and post-ICDMP-initiation periods. This change in the slopes was significant for all of the models except for congestive heart failure in southern Indiana. Thus, the average per member claims paid was increasing at a faster rate before ICDMP but slowed once the program was initiated. To distinguish shorter and longer-term effects related to ICDMP, we estimated annual slopes within the pre- and post-ICDMP- time periods. A similar pattern was found in all regions: claims were increasing before ICDMP, flattened in the years around program initiation, and remained flat in the final year of follow-up.
  
  
  CONCLUSIONS
  : This analysis shows that the trend in average total claims changed significantly after the implementation of ICDMP, with a decline in the rate of increase in claims paid observed for targeted Medicaid program populations across the state of Indiana.
authors.affiliation: Division of Biostatistics, Department of Medicine, School of Medicine, Indiana University, Indianapolis, Indiana, USA. bkatz@iupui.edu
authors.forename: Barry P
authors.initials: BP
authors.lastname: Katz
authors.forename: Ann M
authors.initials: AM
authors.lastname: Holmes
authors.forename: Timothy E
authors.initials: TE
authors.lastname: Stump
authors.forename: Steven M
authors.initials: SM
authors.lastname: Downs
authors.forename: Alan J
authors.initials: AJ
authors.lastname: Zillich
authors.forename: Ronald T
authors.initials: RT
authors.lastname: Ackermann
authors.forename: Thomas S
authors.initials: TS
authors.lastname: Inui
mesh_terms: D000328:Adult; D000368:Aged; D003362:Cost-Benefit Analysis / Q000191:economics; D003920:Diabetes Mellitus / Q000191:economics / Q000453:epidemiology* / Q000628:therapy; D019468:Disease Management; D005260:Female; D017048:Health Care Costs / Q000706:statistics & numerical data; D006333:Heart Failure / Q000191:economics / Q000453:epidemiology* / Q000628:therapy; D006801:Humans; D007196:Indiana; D007344:Insurance Claim Reporting / Q000191:economics / Q000706:statistics & numerical data*; D008137:Longitudinal Studies; D008297:Male; D008484:Medicaid / Q000191:economics / Q000706:statistics & numerical data*; D008875:Middle Aged; D014481:United States